These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6757596)

  • 21. Aspirin and the risk of hemorrhagic stroke.
    Rosenberg R
    J Fam Pract; 1999 Mar; 48(3):169-70. PubMed ID: 10086752
    [No Abstract]   [Full Text] [Related]  

  • 22. Aspirin as an antithrombotic drug: from the aggregometer to clinical trials.
    de Gaetano G
    Verh K Acad Geneeskd Belg; 1990; 52(6):459-71; discussion 471-3. PubMed ID: 2150736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin E, a modifier of platelet function: rationale and use in cardiovascular and cerebrovascular disease.
    Steiner M
    Nutr Rev; 1999 Oct; 57(10):306-9. PubMed ID: 10575906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
    Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR
    Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
    [No Abstract]   [Full Text] [Related]  

  • 25. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

  • 26. [Myocardial infarct, stroke and vascular events reduced by a third].
    Z Kardiol; 1997 Nov; 86(11 Suppl Myokardinf):1-3. PubMed ID: 9437253
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.
    Stuckey TD; Kirtane AJ; Brodie BR; Witzenbichler B; Litherland C; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Mehran R; Généreux P; Ben-Yehuda O; Simonton CA; Stone GW;
    JACC Cardiovasc Interv; 2017 Aug; 10(16):1607-1617. PubMed ID: 28780034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 29. Aspirin and the prevention of stroke after transient ischaemic attack.
    Warlow C
    Monogr Atheroscler; 1986; 14():203-6. PubMed ID: 3526126
    [No Abstract]   [Full Text] [Related]  

  • 30. Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
    Passamani ER
    Circulation; 1980 Dec; 62(6 Pt 2):V106-10. PubMed ID: 7002348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study.
    Steering Committee of the Physicians' Health Study Research Group
    N Engl J Med; 1988 Jan; 318(4):262-4. PubMed ID: 3275899
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
    Sherry S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
    [No Abstract]   [Full Text] [Related]  

  • 33. Aspirin versus clopidogrel: the wrong question?
    Born GV; Collins R
    Lancet; 1997 Mar; 349(9054):806-7. PubMed ID: 9074601
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical trials of platelet-active drugs in coronary heart disease: summary of design features.
    Furberg CD; May GS
    Circulation; 1980 Dec; 62(6 Pt 2):V49-52. PubMed ID: 7002352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet suppressing drugs in arterial disease.
    Blakely JA
    Thromb Haemost; 1978 Apr; 39(2):294-303. PubMed ID: 580983
    [No Abstract]   [Full Text] [Related]  

  • 36. The current status of platelet suppressive drugs in the treatment of thrombosis.
    Hirsh J; Gent M; Genton E
    Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213
    [No Abstract]   [Full Text] [Related]  

  • 37. [Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
    Shalaev SV
    Kardiologiia; 1989 Sep; 29(9):116-20. PubMed ID: 2687554
    [No Abstract]   [Full Text] [Related]  

  • 38. [Controversy on platelet-inhibiting drugs].
    Oelz O
    Schweiz Med Wochenschr; 1985 May; 115(20):703-7. PubMed ID: 3892659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of stroke.
    Barnett HJ
    Int Anesthesiol Clin; 1984; 22(3):11-29. PubMed ID: 6384054
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current clinical results of antiplatelet medication].
    Ordinas A
    Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.